Product Images Daxxify
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Daxxify NDC 72960-112 by Revance Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - daxxify 01
Figure 2 - Study GL-1 - daxxify 02
Figure 2 - Study GL-2 - daxxify 03
This text seems to be a table or a section of a scientific study report. It shows some numerical data that represents the percentage of subjects or patients that are grouped in some categories. It also includes some information on "Study GL-2". Without further context, it is not clear what this data represents or what the categories mean.*
PRINCIPAL DISPLAY PANEL - 1.2 mL Vial Carton - daxxify 04
This is a description of a pharmaceutical product named "DAXXIFY". It is a type of botulinum toxin, and the only available information seems to be related to dosage and storage. The product comes in single-dose vials and should be discarded if unused. Dosage instructions should be followed carefully. The text warns against using dosing units from different commercial products. There are no preservatives in the product, and it should be kept away from children and stored at room temperature or refrigerated before use. The product must be used within 72 hours after reconstitution and should not be frozen. "DAXXIFY" is a trademark of REVANCE Therapeutics, Inc.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
